Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback